Rock Springs Capital Management’s Novo Nordisk NVO Stock Holding History

Rock Springs Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.04M	Sell	63,500 -26,500	-29%	-$1.14M	0.15%	85
2026 Q1	$3.31M	Buy	+90,000	New	+$4.26M	0.19%	75
2024 Q4	–	Sell	-132,000	Closed	-$15.7M	–	117
2024 Q3	$15.7M	Sell	132,000 -15,500	-11%	-$2.07M	0.51%	54
2024 Q2	$21.1M	Hold	147,500	–	–	0.63%	50
2024 Q1	$18.9M	Buy	+147,500	New	+$17.6M	0.48%	60

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rock Springs Capital Management's NVO Position: Q2 2026 in Review

Rock Springs Capital Management reduced its Novo Nordisk (NVO) stake by 29% in Q2 2026, selling an estimated $1.14M and leaving 63,500 shares worth $3.04M. The position accounts for 0.15% of the portfolio, ranked #85.

Rock Springs Capital Management first reported a position in NVO in Q1 2024 and has held it in 5 quarters since. The position peaked at $21.1M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Rock Springs Capital Management held 63,500 shares of Novo Nordisk worth $3.04M as of Q2 2026.
Rock Springs Capital Management sold 26,500 Novo Nordisk shares in Q2 2026, an estimated $1.14M.
Novo Nordisk made up 0.15% of Rock Springs Capital Management's portfolio in Q2 2026, its #85 holding.
Rock Springs Capital Management first reported a position in Novo Nordisk in Q1 2024 and has held it in 5 quarters since.
Rock Springs Capital Management's Novo Nordisk position peaked at $21.1M in Q2 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Rock Springs Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.